Jun Masuda

Ariake, 1358550, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.

Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: July 02, 2026

AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC.

AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC.

Journal: International journal of clinical oncology

Published: June 14, 2026

Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.

Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.

Journal: Breast disease

Published: December 05, 2025

National Cancer Control in a Super-Aged Society-Based on the Fourth Basic Plan to Promote Cancer Control

National Cancer Control in a Super-Aged Society-Based on the Fourth Basic Plan to Promote Cancer Control

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 12, 2025

Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.

Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.

Journal: Breast cancer (Tokyo, Japan)

Published: September 17, 2024

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial).

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial).

Journal: Journal for immunotherapy of cancer

Published: August 08, 2023

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.

Journal: Breast cancer research and treatment

Published: July 07, 2022

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.

Journal: Cancer reports (Hoboken, N.J.)

Published: September 07, 2021

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.

Journal: BMC cancer

Published: February 15, 2021

Targeting Oncoimmune Drivers of Cancer Metastasis.

Targeting Oncoimmune Drivers of Cancer Metastasis.

Journal: Cancers

Published: December 22, 2020

Pembrolizumab plus chemotherapy in triple-negative breast cancer.

Pembrolizumab plus chemotherapy in triple-negative breast cancer.

Journal: Lancet (London, England)

Published: December 19, 2020

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center.

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center.

Journal: Cancer cell

Published: December 19, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026